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Michael Kuhne, MD, Thomas Crawford, MD, Nagib Chalfoun, MD, Darryl Wells, MD,
Warangkna Boonyapisit, MD, Srikar Veerareddy, MD, Sreedhar Billakanty, MD, Wai S. Wong, MD,
Eric Good, DO, Krit Jongnarangsin, MD, Frank Pelosi, JR, MD, Frank Bogun, MD, Fred Morady, MD
Ann Arbor, Michigan
Objectives This study sought to determine whether ablation of complex fractionated atrial electrograms (CFAEs) after antral
pulmonary vein isolation (APVI) further improves the clinical outcome of APVI in patients with long-lasting persis-
tent atrial fibrillation (AF).
Background Ablation of CFAEs has been reported to eliminate persistent AF. However, residual pulmonary vein arrhythmoge-
nicity is a common mechanism of recurrence.
Methods In this randomized study, 119 consecutive patients (mean age 60  9 years) with long-lasting persistent AF un-
derwent APVI with an irrigated-tip radiofrequency ablation catheter. Antral pulmonary vein isolation resulted in
termination of AF in 19 of 119 patients (Group A, 16%). The remaining 100 patients who still were in AF were
randomized to no further ablation and underwent cardioversion (Group B, n  50) or to ablation of CFAEs in the
left atrium or coronary sinus for up to 2 additional hours of procedure duration (Group C, n  50).
Results Atrial fibrillation terminated during ablation of CFAEs in 9 of 50 patients (18%) in Group C. At 10  3 months
after a single ablation procedure, 18 of 50 (36%) in Group B and 17 of 50 (34%) in Group C were in sinus
rhythm without antiarrhythmic drugs (p  0.84). In Group A, 15 of 19 patients (79%) were in sinus rhythm. A
repeat ablation procedure was performed in 34 of 100 randomized patients (for AF in 30 and atrial flutter in 4).
At 9  4 months after the final procedure, 34 of 50 (68%) in Group B and 30 of 50 (60%) in Group C were in
sinus rhythm without antiarrhythmic drugs (p  0.40).
Conclusions Up to 2 h of additional ablation of CFAEs after APVI does not appear to improve clinical outcomes in patients
with long-lasting persistent AF. (J Am Coll Cardiol 2009;53:782–9) © 2009 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.10.054s
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linus rhythm can be maintained in approximately 75% of
atients with long-standing persistent atrial fibrillation
AF) after circumferential pulmonary vein (PV) ablation (1).
blation of complex fractionated atrial electrograms
CFAEs) without necessarily isolating the PVs has also
een reported to eliminate persistent AF (2). However,
xcept in 1 study (2), the clinical efficacy of ablation of
FAEs has been only modest (3), and a recent study
rom the Division of Cardiovascular Medicine, Cardiovascular Center, University of
ichigan, Ann Arbor, Michigan. Drs. Oral and Morady are founders and equity
wners of Ablation Frontiers Inc. Dr. Oral has received research grants from St. Jude
edical and Boston Scientific.w
Manuscript received July 24, 2008; revised manuscript received September 16,
008, accepted October 8, 2008.uggested that residual PV arrhythmogenicity accounts
or a majority of recurrences after ablation of CFAEs
3,4). Therefore, it is possible that ablation of CFAEs
ould be more helpful if performed in conjunction with
ntral pulmonary vein isolation (APVI) rather than as a
tand-alone ablation strategy. However, there are no
See page 790
tudies that prospectively assessed the clinical utility of
blation of CFAEs after APVI in patients with long-
asting persistent AF.
The purpose of this randomized study was to determine
hether ablation of CFAEs in patients with long-lasting
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March 3, 2009:782–9 Complex Electrograms in AFersistent AF who remain in AF after APVI is associated
ith a higher probability of maintaining sinus rhythm than
PVI alone.
ethods
tudy subjects. There were 119 consecutive patients who
onsented to participate in this study to eliminate their long-
asting persistent AF. There were 96 men and 23 women, and
heir mean age was 60  9 years (range 33 to 80 years). The
ean left atrial size and left ventricular ejection fraction were
6  6 mm and 0.53  0.10, respectively. Atrial fibrillation
ad been persistent for 5 5 years before ablation. The clinical
haracteristics of patients in each group are shown in Table 1.
atients who had undergone a prior ablation procedure for AF
ere excluded from this study.
lectrophysiologic study. All patients provided informed
ritten consent. An electrophysiologic study was performed
n the fasting state. All antiarrhythmic drugs except amio-
arone were discontinued at least 4 to 5 half-lives before the
tudy. Amiodarone was discontinued 8 weeks earlier. All
ascular access was obtained through a femoral vein. A
uadripolar catheter positioned in the coronary sinus was
sed for recording electrograms and atrial pacing. After
ransseptal puncture, systemic anticoagulation was achieved
ith intravenous heparin to maintain an activated clotting
ime of 325 to 350 s. All PVs were mapped with a decapolar
ing catheter (Lasso, Biosense Webster, Diamond Bar,
alifornia). An open-irrigation, 3.5-mm-tip deflectable tip
atheter (Thermocool, Biosense Webster) was used for
apping and ablation. Bipolar electrograms were recorded
t a bandpass of 30 to 500 Hz (EPMedSystems, West
erlin, New Jersey).
An electroanatomical mapping system (Carto, Biosense
ebster) was used to reconstruct the 3-dimensional geometry
f the left atrium and PVs. To avoid inadvertent collateral
njury, the esophagus was visualized by barium swallow (5).
fter the barium swallow, conscious sedation was achieved
ith midazolam and fentanyl.
linical Characteristics
Table 1 Clinical Characteristics
Group A:
AF Terminated During APVI
(n  19)
Ra
Age, yrs 60 7
Sex, male/female 14/5
Duration of AF, yrs 4 4
Left atrial diameter, mm 42 5
Left ventricular EF 0.54 0.10
Structural heart disease 14 (74)
Coronary artery disease 3 (16)
Nonischemic cardiomyopathy 4 (21)
Valvular heart disease 2 (11)
Hypertensive heart disease 11 (58)
Amiodarone before RFA 1 (5)ata are shown as mean  SD or n (%). *p  0.05 (Tukey test) when compared with Group 1.
AF  atrial fibrillation; APVI  antral pulmonary vein isolation; CFAE  complex fractionated atrial eleRadiofrequency energy was
elivered at a maximum power
utput of 35 W at a flow rate of
0 ml/min and a maximum tem-
erature of 45°C. The power was
educed to 20 to 25 W at a flow
ate of 17 ml/min, during appli-
ations of energy near the PV
stia, in the posterior left atrium,
r in the coronary sinus. The end
oint of each individual applica-
ion at a given site was voltage abatement or up to 40 s of
pplication with adequate tissue contact and power delivery.
tudy protocol. The study protocol was approved by the
nstitutional Review Board. All patients presented in AF.
irst, all patients underwent APVI to target CFAEs within
he antrum of the PVs, with an end point of complete
lectrical isolation of all PVs (Fig. 1). This study defined
FAEs as electrograms with a cycle length 120 ms or
horter than the AF cycle length in the coronary sinus, or
lectrograms that were fractionated or displayed continuous
lectrical activity (Fig. 2) (3).
APVI was completed in all patients and complete PV
solation was achieved whether or not AF terminated during
he procedure. Because termination of AF by catheter
blation has been associated with a more favorable clinical
utcome in patients with paroxysmal and persistent AF
3,6,7), patients with termination of AF during APVI did
ot undergo additional ablation of CFAEs (Group A).
atients who still had AF after APVI were randomly
ssigned to undergo no further ablation (Group B) or to
ndergo additional ablation of CFAEs in the left atrium
nd coronary sinus up to 2 additional hours of procedure
uration or until AF terminated, whichever came first
Group C) (Fig. 3).
In patients who remained in AF, sinus rhythm was
estored by pharmacological cardioversion with ibutilide or
ransthoracic cardioversion.
Abbreviations
and Acronyms
AF  atrial fibrillation
APVI  antral pulmonary
vein isolation
CFAE  complex
fractionated atrial
electrogram
PV  pulmonary vein
Group B:
ized to APVI Only
(n  50)
Group C:
Randomized to APVI  CFAE RFA
(n  50) p Value
58 10 62 8 0.16
41/9 41/9 0.70
6 5 5 4 0.48
47 6* 46 6* 0.03
.53 0.12 0.54 0.09 0.72
36 (72) 37 (74) 0.97
8 (16) 9 (18) 0.96
11 (22) 9 (18) 0.89
3 (6) 2 (4) 0.59
32 (64) 29 (58) 0.80
6 (12) 2 (4) 0.34ctrogram; EF  ejection fraction; RFA  radiofrequency cndom
0atheter ablation.
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Complex Electrograms in AF March 3, 2009:782–9ost-ablation management and follow-up. All patients
ere discharged home the next day taking warfarin and low
olecular weight heparin until the international normalized
atio was 2.0. The same drug regimen was continued for
to 12 weeks after ablation in patients who were receiving
n antiarrhythmic drug before the procedure.
The first outpatient clinic visit was at 3 months after the
blation procedure. The patients then were seen every 3 to
months. Patients were also asked to call a clinical
oordinator if they experienced symptoms suggestive of an
rrhythmia. The patients were provided with a 30-day
utotriggered event monitor 6 months after ablation. A
epeat ablation procedure was offered to all patients with
ecurrent atrial arrhythmias. During repeat ablation, APVI
as confirmed and repeated in all patients if there was
ecovery of conduction. At the discretion of the operator,
FAEs were also targeted until AF terminated or all
FAEs were eliminated, regardless of the initial random-
zation group.
Warfarin was discontinued in patients who were con-
rmed to be in sinus rhythm beyond 6 months after the final
blation procedure as long as there was no history of
hromboembolic events or another indication to continue
nticoagulant therapy (8).
tatistical analysis. Continuous variables are expressed as
ean  1 SD and were compared by Student t test or by
nalysis of variance. The Tukey test was performed for post
oc analyses. Categorical variables were compared by chi-
quare analysis or with the Fisher exact test as appropriate.
LS PV
RI PV
LA appendage
RS PV
LI PV
A
1.
Figure 1 Antral PV Isolation
Shown are left lateral (A) and posteroanterior (B) projections of a 3-dimensional e
Red tags indicate ablation sites. LI  left inferior; LS  left superior; PV  pulmop value 0.05 indicated statistical significance. TTo detect a 25% difference in clinical outcome at a power
f 0.80 and 1-tailed alpha of 0.05, 46 patients in each group
ould be necessary. Therefore, 50 patients were randomly
ssigned to Groups B and C. The primary end point of the
tudy was freedom from symptomatic and asymptomatic AF
nd other atrial tachyarrhythmias in the absence of antiar-
hythmic drug therapy after a single ablation procedure.
ny episode of atrial tachyarrhythmia 30 s in duration
eyond 12 weeks after ablation was considered to be a
ecurrence.
esults
PVI and subsequent randomization. All PVs were com-
letely isolated in all patients during APVI. The mean
uration of radiofrequency energy application was 54  19
in. The mean fluoroscopy and procedure times were 59 
3 min and 254  47 min, respectively.
Among the 119 patients, AF terminated in 19 (16%,
roup A): to sinus rhythm in 16 and to atrial tachycardia/
utter in 3. The remaining 100 patients with AF after
PVI were randomized to no further ablation (Group B,
 50) or to ablation of CFAEs (Group C, n  50). The
linical and echocardiographic characteristics of patients
mong the 3 groups were similar except for the left atrial
ize. Patients in Group A had a smaller left atrial diameter
han patients in Groups B and C (Table 1).
blation of CFAEs (Group C). The sites of CFAEs
argeted in the left atrium and coronary sinus are shown in
RI PV
RS PV
LI PV
S PV
B
1.25 cm
anatomic depiction of the left atrium (LA).
ein; RI  right inferior; RS  right superior.L
25 cm
lectro
nary vable 2. Ablation was performed within the coronary sinus
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March 3, 2009:782–9 Complex Electrograms in AFn 24 of 50 (48%) patients. The mean duration of radiofre-
uency energy application to eliminate CFAEs was 33 22
in. The mean additional fluoroscopy and procedure dura-
ions for ablation of CFAEs were 20 14 min and 75 77
in, respectively.
Atrial fibrillation terminated in 9 of 50 patients (18%) in
roup C during ablation of CFAEs: to sinus rhythm in 5
nd to atrial tachycardia/flutter in 4. Due to the length of
he procedure, sinus rhythm was restored by ibutilide
n  1) or transthoracic cardioversion (n  3) in patients
ho had atrial flutter. In the remaining 41 patients, sinus
hythm was restored by ibutilide infusion (n  11) or by
ransthoracic cardioversion (n  30).
aintenance of sinus rhythm after a single ablation
rocedure. At a mean follow-up of 10  3 months after
single ablation procedure, 19 of 50 patients (38%) in
roup B and 18 of 50 patients (36%) in Group C were in
Abl
CS
Abl
CS
A
B
C Abl
CS
CS
Abl
D
Figure 2 Examples of CFAEs
Examples of complex fractionated atrial electrograms (CFAEs). Abl  distal bipoleinus rhythm in the absence of antiarrhythmic drug pherapy (p  0.84). Among the 31 of 50 patients in
roup B who had recurrent atrial arrhythmias, 23 (46%)
ad persistent AF, 6 (12%) had paroxysmal AF, and 2
4%) had atrial flutter. Among the 32 of 50 patients in
roup C who had recurrent atrial arrhythmias, 24 (48%)
ad persistent AF, 2 (4%) had paroxysmal AF, and 6
12%) had atrial flutter (p  0.14 for atrial flutter) during
mean follow-up of 10  3 months.
At a mean follow-up of 10  3 months after a single
blation procedure, among the 19 patients in Group A in
hom AF terminated during APVI, 15 (79%) were in sinus
hythm without antiarrhythmic drug therapy and 4 (21%)
ad recurrent AF.
Among the 100 randomized patients, there were no
redictors of sinus rhythm after a single ablation procedure.
mong all 119 study patients, sinus rhythm was maintained
n the absence of antiarrhythmic drug therapy in 18 of 28
300 msec
300 msec
300 msec
300 msec
ablation catheter; CS  distal bipole of the coronary sinus catheter.of theatients (64%) in whom AF terminated during ablation and
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Complex Electrograms in AF March 3, 2009:782–9n 34 of 91 patients (37%) in whom AF persisted after
blation (p 0.01). There were no other predictors of sinus
hythm after a single ablation procedure.
epeat ablation procedures. In 119 patients, 157 proce-
ures were performed. A second ablation procedure was
erformed in 1 of 19 patients (5%) in Group A, 18 of 50
atients (36%) in Group B, and 17 of 50 patients (34%)
n Group C at a mean of 7  2 months after the first
rocedure (p  0.83 for Group B vs. C). The second
rocedure was performed for recurrent AF in 32 patients
1 in Group A, 17 in Group B, and 14 in Group C) and
trial flutter in 4 patients (1 in Group B and 3 in Group
). A third ablation procedure was performed in 1
atient in Group A for recurrent AF and 1 patient in
LS PV
RI PV
A
LA appenRS PV
1.35
Figure 3 Ablation of CFAEs
Shown are right anterior oblique (A) and posteroanterior (B) projections of a 3-dim
electroanatomic depiction of the LA. Red tags indicate ablation sites. Abbreviation
eft Atrial Sites WhereFAEs Were Ablated in All Patients
Table 2 Left Atrial Sites WhereCFAEs Were Ablated in All Patients
Left Atrial Site % Patients (n  50)
PV antrum or ostium 100
Base of LAA 84
Roof 78
Septum 73
Anterior wall 73
Posterior annulus 58
Mitral isthmus 44
Posterior wall 36
Coronary sinus 481AA  left atrial appendage; PV  pulmonary vein; other abbreviation as in Table 1.roup C for recurrent atrial flutter 5 and 7 months after
he second procedure.
During the repeat ablation procedures, CFAEs were
dentified near 1 PVs in all patients and were ablated by
stial and/or antral applications of radiofrequency energy.
here was recovery of conduction to 1 PVs in all
atients. APVI was confirmed in all patients. Additional
blation of CFAEs was performed at the discretion of the
perator. Including the repeat ablation procedures in the
00 randomized patients, 40 patients were treated by
PVI alone, and 60 patients had additional ablation of
FAEs after APVI during the first, repeat, or both
rocedures.
linical outcome after repeat procedures. At a mean of
 4 months after the last ablation procedure, 15 of 19
atients (79%) in Group A, 34 of 50 patients (68%) in
roup B, and 30 of 50 patients (60%) in Group C were in
inus rhythm without antiarrhythmic drug therapy (p 
.40 for Group B vs. C).
Among the 19 patients in Group A, 4 (21%) remained in
F. Among the 16 patients in Group B who had recurrent
trial arrhythmias, 9 (18%) had persistent AF, 5 (10%) had
aroxysmal AF, and 2 (4%) had atrial flutter. Among the 20
atients in Group C who had recurrent atrial arrhythmias,
2 (24%) had persistent AF, 2 (4%) had paroxysmal AF,
nd 6 (12%) had atrial flutter.
After 9  4 months after the final procedure, among the
RI PV
RS PV
V
S PV
Coronary sinus
B
e
1.35 cm
nal
n Figures 1 and 2.LI P
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March 3, 2009:782–9 Complex Electrograms in AFnderwent APVI and 36 of 60 patients (60%) who also had
blation of CFAEs after APVI during the first, repeat, or
oth procedures, were in sinus rhythm in the absence of
ntiarrhythmic drug therapy (p  0.45). Among the 40
atients who only had APVI, 8 (20%) had persistent AF, 5
12%) had paroxysmal AF, and none had recurrent atrial
utter; whereas among the 60 patients who also had
blation of CFAEs, 14 (23%) had persistent AF, 2 (3%) had
aroxysmal AF, and 8 (13%) had atrial flutter (p  0.02 for
trial flutter).
omplications. After 157 ablation procedures in 119 pa-
ients, 2 patients developed transient pericarditis and 1
atient had a small pericardial effusion without tamponade.
here were 2 vascular complications, including a self-
imited extraperitoneal bleed and a femoral arteriovenous
stula.
iscussion
ain findings. This study demonstrates that up to 2 h of
dditional ablation of CFAEs outside of the antral regions
n patients who remained in AF after APVI did not improve
he clinical efficacy of APVI. Regardless of whether or not
FAEs were also targeted, APVI resulted in maintenance
f sinus rhythm in the absence of antiarrhythmic drug
herapy in70% of patients with long-lasting persistent AF
fter 1 to 2 ablation procedures.
PVI. The mechanisms by which APVI exerts its benefi-
ial effects may include: 1) elimination of PV tachycardias
hat initiate (9) and perpetuate AF (7,10); 2) exclusion of
V antrum, which has similar histoembryologic properties
nd arrhythmogenic activity to that of the PVs (11);
) elimination of anchor points of high-frequency sources
uch as rotors (12–14); 4) ablation of ganglionated plexi
nd/or “AF nests” in the proximity of the PV antra (15–19);
nd 5) debulking of the left atrium by 25% to 30% so that
circuit can no longer accommodate a wavelength within
he effective refractory period and conduction velocity of the
eft atrium (20,21).
Although termination of AF is infrequent during APVI,
majority of patients remain in sinus rhythm after 1 to 2
ttempts at APVI. APVI may eliminate triggers/initiators
r primary drivers of AF and may modulate the inducibility
nd sustainability of AF by altering autonomic innervation.
esidual drivers beyond the PV antra may not be able to
elf-initiate or sustain after APVI (22). Because recovery of
V conduction is a common observation and may be equally
ikely in patients with and without recurrences (23,24) and
ecause the number of completely isolated PVs does not
ecessarily predict clinical outcome (25), the efficacy of
PVI clearly depends on more than elimination of PV
rrhythmogenicity.
Because APVI has a modest clinical efficacy of 70% for
ersistent AF, it is clear that APVI does not eliminate all
otential drivers of AF. On the other hand, ablation of
FAEs without completely isolating all PVs has been eeported to terminate AF in some patients and eliminate AF
n a majority of patients with paroxysmal and persistent AF
2,3,26). Termination of AF indicates effective elimination
f most, if not all, drivers of AF and is associated with a
ore favorable outcome, as was the case in this study
7,27–29). Therefore, targeting CFAEs after APVI may be
eneficial by eliminating drivers of AF not typically elimi-
ated by APVI.
argeting CFAEs to eliminate residual drivers of AF. Based
n the commonly used criteria of electrogram fractionation,
ontinuous electrical activity, or short cycle length, CFAEs
re ubiquitous in the atria and coronary sinus, suggesting
imited specificity (30). Prior studies suggested that CFAEs
ay indicate sites of slow conduction, collision, anchor
oints for reentrant circuits (31), wavebreak and fibrillatory
onduction at the periphery of a rotor or an anatomical
arrier such as the septopulmonary bundle (32,33), or sites
f autonomic innervation (34). High-frequency electro-
rams have been suggested to indicate sites close to a rotor.
owever, in a prior study (30), 3% of all atrial sites
emonstrated electrograms with a cycle length 120 ms, a
idely used criterion for CFAEs. CFAEs may also repre-
ent passive depolarization due to anisotropy and summa-
ion of electrograms from overlapping layers of myocardium
35,36).
Atrial fibrillation terminated in 35% of patients during
nitial APVI in 16% and during additional ablation of
FAEs in 18% of the patients in this study. This conversion
ate is lower than reported in 2 other studies (2,28). In a
tudy by Nademanee et al. (2), 63% of 64 patients with
hronic AF had termination of AF. In a study by Haïs-
aguerre et al. (28), which used a stepwise approach, AF
erminated in 87% of 60 patients. In the first study (2),
FAEs in the right atrium were also targeted. However a
rior study (29) demonstrated that additional ablation of
FAEs in the right atrium increased the conversion rate by
nly 3%. In the study of stepwise ablation (28), linear
blation along the roof and mitral isthmus had to be
erformed in50% of patients to terminate AF and the end
oint of ablation was termination of AF using a variety of
blation strategies. However, in the present study, linear
blation was not performed, and the purpose of the study
as to assess only the incremental value of CFAE ablation
fter APVI.
tudy limitations. CFAEs were identified in the time
omain by visual inspection. However, similar criteria have
een widely accepted and used in prior studies (2). Further-
ore, a recent study (37) that used automated electro-
raphic analysis reported rates of termination and freedom
rom AF similar to those observed in this study.
A second limitation is that during repeat procedures
FAEs were targeted at the discretion of the operator
ithout a randomization scheme. However, the clinical
haracteristics of both groups of patients were similar.
urthermore, the primary end point of the study was clinical
fficacy after a single ablation procedure.
w
d
a
C
T
p
s
h
A
a
n
A
c
o
o
a
b
d
s
t
r
w
v
l
d
R
v
A
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
788 Oral et al. JACC Vol. 53, No. 9, 2009
Complex Electrograms in AF March 3, 2009:782–9A third consideration is that CFAEs in the right atrium
ere not targeted in this study. However, a prior study (29)
emonstrated that routine ablation of CFAEs in the right
trium was not incremental to left atrial ablation.
linical Implications and Future Directions
he purpose of this study was to determine whether a
ractical approach of simply ablating left atrial and coronary
inus CFAEs for up to 2 additional hours of procedure time
as any incremental clinical value above and beyond APVI.
mean of 33 min of radiofrequency energy was devoted to
blation of CFAEs outside the antral regions, but this did
ot offer any improvement in clinical efficacy compared with
PVI alone in patients with long-standing persistent AF. It
ertainly is possible that more extensive and biatrial ablation
f CFAEs may improve clinical efficacy, but this would
ften require procedure times 5 to 6 h.
The relatively modest efficacy of APVI with or without
dditional ablation of CFAEs highlights the need for a
etter strategy for identifying and eliminating residual
rivers of AF beyond the PVs than targeting CFAEs. A
tepwise approach to ablation of persistent AF was reported
o have high clinical efficacy, but only after a redo ablation
ate50% and not in a homogeneous population of patients
ith long-lasting persistent AF. The cost-benefit analysis of
ery extensive ablation with an end point of conversion of
ong-lasting persistent AF to sinus rhythm remains to be
etermined.
eprint requests and correspondence: Dr. Hakan Oral, Cardio-
ascular Center, SPC 5853, 1500 E. Medical Center Drive, Ann
rbor, Michigan 48109-5853. E-mail: oralh@umich.edu.
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